Sign In
Buy KDMN
$9.50
+0 (+0%)
At Close: Aug 17, 2022
Iovance Biotherapeutics (IOVA) Received its Third Buy in a Row
11:25am, Wednesday, 26'th Feb 2020
After Piper Sandler and Cowen & Co. gave Iovance Biotherapeutics (NASDAQ: IOVA) a Buy rating last month, the company received
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
Kadmon Announces Expanded Results of Interim Analysis of Pivotal Trial of KD025 in cGVHD
05:29pm, Sunday, 23'rd Feb 2020
Patient Analyses and Safety Data Continue to Underscore Positive Impact of KD025 in cGVHD Pre-NDA Meeting with FDA Planned for March 2020; Topline Results of Primary Analysis to be Announced in Q2 202
Tracking Dan Loeb's Third Point Portfolio - Q4 2019 Update
03:05am, Tuesday, 18'th Feb 2020
Dan Loeb's 13F portfolio value increased from $8.42B to $8.70B this quarter. The number of positions decreased from 40 to 37. Third Point added IAA, Inc. while
3 Healthcare Stocks With Important Catalysts in Q1
02:33pm, Wednesday, 22'nd Jan 2020
Blink, and you might just miss it. We are referring to the colossal gains that can be achieved by a select group of stocks in almost no time at all, namely those inhabiting the healthcare sector. But
6 Cheap Stocks to Buy Under $7
03:22pm, Wednesday, 15'th Jan 2020
No matter what, investors are always after returns. These six cheap stocks can make those returns a reality in 2020.
Kadmon Announces Acceptance of Late-Breaking Abstract of KD025 for cGVHD at the 2020 TCT Meetings
09:15pm, Friday, 10'th Jan 2020
NEW YORK, NY / ACCESSWIRE / January 10, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced that expanded data from the interim analysis of ROCKstar (KD025-213), its ongoing pivotal trial of KD02
Kadmon, BeyondSpring gain a bull as Nomura picks up coverage
03:05pm, Friday, 10'th Jan 2020
BeyondSpring (NASDAQ:BYSI) rises 2.7% and Kadmon Holdings (NYSE:KDMN) also gains 2.7% after Nomura Instinet initiates coverage of the two companies at Buy.BeyondSpring is testing plinabulin in mul
Morgan Stanley sees 15% upside in McKesson in premarket analyst action
12:32pm, Friday, 10'th Jan 2020
Aerie Pharmaceuticals (NASDAQ:AERI) initiated with Neutral rating and $27 (6% upside) price target at Bank of America.Aurinia Pharmaceuticals (AUP CN) initiated with Buy rating and C$35.26 (32% upside
Investors Who Bought Kadmon Holdings (NYSE:KDMN) Shares A Year Ago Are Now Up 90%
01:34pm, Monday, 06'th Jan 2020
The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...
